Constantine Si Lun Tam, MBBS, MD Peter MacCallum Cancer Centre University of Melbourne 5Live #ASCO20
1:43
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Key Insights on Three-year follow-up of treatment-naïve and previously treated patients with Waldenström macroglobulinemia (WM) receiving single-agent zanubrutinib
Non-Hodgkin Lymphoma Similar Videos
-
Amitkumar Mehta, MD; University of Alabama at Birmingham O’Neal Comprehensive Cancer Center; 5Live #ASH21
8:55
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Matthew Lunning, DO, FACP; University of Nebraska Medical Center; 5Live #ASH21
4:55
Key insights from the 2021 Annual Hematology meeting in Atlanta
-
Risk stratification and therapy for high-grade NHL_Kristie Blum, MD; #DDHO2021
2:27